文献速递手外科与足踝外科

低风险手部手术前的低价值检查是否与下游医疗使用和报销增加相关?一项全国理赔数据库分析

Is Low-value Testing Before Low-risk Hand Surgery Associated With Increased Downstream Healthcare Use and Reimbursements? A National Claims Database Analysis.
PubMed 文献 · Clin Orthop Relat Res · 2022-05-24

该回顾性对比研究基于2011至2017年全国理赔数据库,纳入73,112例接受低风险手部手术的成人患者,其中27%(19,453例)术前30天内至少接受一项低价值检查。经倾向评分匹配和多变量回归分析,低价值检查组术后90天下游诊断检查或操作的发生风险升高(调整OR 1.57,95%CI 1.50至1.64,p<0.001),且与下游使用事件相关的每例患者报销中位数更高(231.97美元 vs 191.52美元),调整后差值为每例217.27美元(95%CI 59.51至375.03,p=0.007)。

要点

  • 低风险手部手术前低价值检查仍常见,27%的患者术前30天内至少接受一项。
  • 接受低价值检查者术后90天下游诊断检查或操作风险升高,调整OR 1.57(95%CI 1.50至1.64)。
  • 低价值检查组下游使用相关报销中位数更高,调整后每例多217.27美元(95%CI 59.51至375.03)。

核心结论

  • 低价值检查会产生已知对健康患者获益极小的下游检查与操作,并可能使患者因假阳性结果而暴露于后续不必要的侵入性检查与操作相关的潜在伤害。
  • 低价值检查仍然常见,且低价值检查相关支出的上升趋势表明需要针对支付方和卫生系统层面进行多组分干预。
  • 此类干预应抑制初始低价值检查及可能随之而来的级联反应;未来识别减少手部手术低价值检查的障碍与促进因素的工作可为去实施策略的制定与修订提供信息。

研究设计与样本

  • 回顾性对比研究,使用2011至2017年大型全国健康保险支付方的行政理赔数据,识别接受低风险手部手术(腕管松解、扳机指松解、Dupuytren筋膜切除术、de Quervain松解、拇指腕掌关节置换、腕部腱鞘囊肿或肿块切除)的成人患者。
  • 共73,112例患者符合纳入标准(平均年龄57±14岁;68%[49,847]为女性),其中27%(19,453)在术前30天内至少接受一项低价值检查(全血细胞计数、基础代谢组合、心电图、胸部X线摄影、肺功能检查、尿液分析),并采用倾向评分与未接受低价值检查者匹配。
  • 采用多变量回归分析评估术后90天内后续诊断检查与操作的发生频率及报销,并控制年龄、性别、合并症和基线医疗使用等潜在混杂变量。

主要发现

  • 控制年龄、性别、合并症和基线医疗使用等协变量后,低价值检查队列术后使用事件(下游诊断检查或操作)的调整OR为1.57(95%CI 1.50至1.64;p<0.001)。
  • 接受低价值检查的患者下游使用事件相关的每例患者报销中位数为231.97美元(IQR 64.37至1138.84),未接受低价值检查者为191.52美元(IQR 57.1至899.42)。
  • 控制协变量后的调整差值为每例患者217.27美元(95%CI 59.51至375.03;p=0.007)。
  • 经通胀调整后,低价值检查队列患者的额外总报销逐年增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minor hand procedures can often be completed in the office without any laboratory testing. Preoperative screening tests before minor hand procedures are unnecessary and considered low value because they can lead to preventable invasive confirmatory tests and/or procedures. Prior studies have shown that low-value testing before low-risk hand surgery is still common, yet little is known about their downstream effects and associated costs. Assessing these downstream events can elucidate the consequences of obtaining a low-value test and inform context-specific interventions to reduce their use. QUESTIONS/PURPOSES: (1) Among healthy adults undergoing low-risk hand surgery, are patients who receive a preoperative low-value test more likely to have subsequent diagnostic tests and procedures than those who do not receive a low-value test? (2) What is the increased 90-day reimbursement associated with subsequent diagnostic tests and procedures in patients who received a low-value test compared with those who did not? METHODS: In this retrospective, comparative study using a large national database, we queried a large health insurance provider's administrative claims data to identify adult patients undergoing low-risk hand surgery (carpal tunnel release, trigger finger release, Dupuytren fasciectomy, de Quervain release, thumb carpometacarpal arthroplasty, wrist ganglion cyst, or mass excision) between 2011 and 2017. This database was selected for its ability to track patient claims longitudinally with direct provision of reimbursement data in a large, geographically diverse patient population. Patients who received at least one preoperative low-value test, including complete blood count, basic metabolic panel, electrocardiogram, chest radiography, pulmonary function test, and urinalysis within the 30-day preoperative period, were matched with propensity scores to those who did not. Among the 73,112 patients who met our inclusion criteria (mean age 57 ± 14 years; 68% [49,847] were women), 27% (19,453) received at least one preoperative low-value test and were propensity score-matched to those who did not. Multivariable regression analyses were performed to assess the frequency and reimbursements of subsequent diagnostic tests and procedures in the 90 days after surgery while controlling for potentially confounding variables such as age, sex, comorbidities, and baseline healthcare use. RESULTS: When controlling for covariates such as age, sex, comorbidities, and baseline healthcare use, patients in the low-value test cohort had an adjusted odds ratio of 1.57 (95% confidence interval [CI] 1.50 to 1.64; p < 0.001) for a postoperative use event (a downstream diagnostic test or procedure) compared with those who did not have a low-value test. The median (IQR) per-patient reimbursements associated with downstream utilization events in patients who received a low-value test was USD 231.97 (64.37 to 1138.84), and those who did not receive a low-value test had a median of USD 191.52 (57.1 to 899.42) (adjusted difference when controlling for covariates: USD 217.27 per patient [95% CI 59.51 to 375.03]; p = 0.007). After adjusting for inflation, total additional reimbursements for patients in the low-value test cohort increased annually. CONCLUSION: Low-value tests generate downstream tests and procedures that are known to provide minimal benefit to healthy patients and may expose patients to potential harms associated with subsequent, unnecessary invasive tests and procedures in response to false positives. Nevertheless, low-value testing remains common and the rising trend in low-value test-associated spending demonstrates the need for multicomponent interventions that target change at both the payer and health system level. Such interventions should disincentivize the initial low-value test and the cascade that may follow. Future work to identify the barriers and facilitators to reduce low-value testing in hand surgery can inform the development and revision of deimplementation strategies. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Welch JM, Zhuang T, Shapiro LM, et al. Is Low-value Testing Before Low-risk Hand Surgery Associated With Increased Downstream Healthcare Use and Reimbursements? A National Claims Database Analysis. Clin Orthop Relat Res. 2022. PMID: 35608508. doi:10.1097/CORR.0000000000002255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。